An FDA-approved drug structurally and phenotypically corrects the K210del mutation in genetic cardiomyopathy models
- Author(s): Wang et al.
- Year: 2025
- DOI: 10.1172/JCI174081
- PMID: 39959972
- Related Products: 315C/322C: High-Speed Length Controllers, 400A: Force Transducers
- Research Areas: Cardiology
- Disease Models: Myopathy